Advancing New Healthcare Solutions Through Collaboration

Tracking the spread of the virus in real time. Analyzing data to learn more about who's most vulnerable. These are just a couple of ways the company's data science team is helping inform how to respond to the pandemic.

The convergence of the events in 2020 and the beginning of 2021 continues to reverberate. Even now, we face economic, social, political and health disparities in how COVID-19 has disproportionately impacted racial and ethnic minorities. Our collective action is required to mount a sustainable recovery—both in restoring equitable access to these fundamental institutions, and in healing deep wounds across all races and ethnicities.

In 2020, JJDC deployed more than 500MM in capital and completed more than 40 investments, maintaining our steadfast commitment to fueling the global entrepreneurial community to solve critical healthcare needs. Learn more about how JJDC is working to foster innovation across the medical device, pharmaceutical and consumer health sectors to advance transformational solutions for patients and consumers around the world.

Johnson & Johnson Innovation is committed to helping patients, our partners and communities around the world manage the unprecedented impact of COVID-19.